Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – Should You Buy?

Shares of Know Labs, Inc. (NYSEAMERICAN:KNW) rose 3.8% during trading on Monday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares changed hands during trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Trading Up 3.8%

The firm has a market cap of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83. The stock’s 50 day moving average is $2.14 and its 200 day moving average is $2.14.

Hedge Funds Weigh In On Know Labs

An institutional investor recently bought a new stake in Know Labs stock. Cerity Partners LLC purchased a new position in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 80,000 shares of the company’s stock, valued at approximately $158,000. Cerity Partners LLC owned about 1.07% of Know Labs at the end of the most recent quarter. 23.96% of the stock is currently owned by institutional investors.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.